SingleGrowth Hormone

EPO 3000 IU

Recombinant human erythropoietin evaluated for its role in stimulating erythropoiesis and tissue oxygenation in research models.

Mechanism

Binds to cell-surface erythropoietin receptors to activate the JAK2-STAT5 intracellular signaling cascade, promoting the proliferation and anti-apoptotic survival of erythroid precursor cells.

Dosing

The laboratory reference highlights an initial experimental threshold of 100 IU for baseline concentration modeling.

Reconstitution

Reconstituting a 3000 IU lyophilized vial with 1.0 mL of bacteriostatic water results in a final research concentration of 3000 IU/mL.

Storage

Keep lyophilized and reconstituted vials refrigerated at 2°C to 8°C protected from light, avoiding physical agitation and freeze-thaw cycles.

Mix & measure EPO 3000 IU

Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.

Mix & measure EPO 3000 IU

Vial strength → BAC water → target dose

Vial strength

BAC water

Target dose

Concentration3000.0mg/mL

Draw volume0.000mL

On the syringe0.003units

Total doses in vial: 30000.0

100u80u60u40u20u0

U-100 syringe: 100 units = 1 mL

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →

Dosing Chart

Phase / Day(s)	Dose & Frequency	Volume (U-100 units / mL)
Baseline Titration	100 IU reference	0.033 mL (3 units)
Low Range Reference	250 IU reference	0.083 mL (8 units)
Mid Range Reference	500 IU reference	0.167 mL (17 units)
High Range Reference	1000 IU reference	0.333 mL (33 units)

Reconstitution Steps

1
Sterilize the rubber septums of both the bacteriostatic water container and the lyophilized EPO vial using sterile alcohol wipes, allowing them to fully dry.
2
Draw 1.0 mL of bacteriostatic water into a designated mixing syringe.
3
Introduce the needle into the vial at an angle, directing the diluent gently down the interior glass wall rather than directly impacting the protein cake.
4
Swirl the vial with smooth, slow motions until the lyophilized cake is fully dissolved, strictly avoiding vigorous agitation to prevent structural denaturation.
5
Transfer the reconstituted biological solution immediately into refrigerated storage maintained between 2°C and 8°C.

Supplies Needed

Peptide Vial

Supplies 3000 IU of freeze-dried recombinant human erythropoietin for scientific investigation.

Insulin Syringes (U-100)

Allows micro-volume liquid measurement and experimental dispensing across standard unit calibrations.

Bacteriostatic Water

Provides 1.0 mL of sterile, preserved liquid solvent required to safely dissolve the lyophilized cake.

Alcohol Swabs

Applied to clean vial stoppers and work surfaces to maintain aseptic handling standards.

Why researchers study it

Regulation of erythropoiesis and anemia response

Aerobic capacity and cellular oxygenation pathways

Thrombotic mechanisms and blood viscosity risks

Isoform identification and bio-detection methods

These describe what is being studied, not proven benefits, approved uses, or promised results.

Overview

Erythropoietin (EPO) is an endogenous glycoprotein hormone primarily biosynthesized by renal cortical interstitial cells in response to tissue hypoxia. In experimental biology, recombinant versions reproduce physiological signaling pathways that trigger the differentiation, maturation, and survival of erythroid progenitor cells within the bone marrow compartment. While clinically applied as an approved biopharmaceutical for specific types of chronic anemia, non-clinical research frequently explores its broader cytoprotective, neuroprotective, and systemic metabolic influences. Due to its direct modulation of hematocrit and circulating erythrocyte mass, precise laboratory quantification remains critical to prevent fluid dynamic disturbances in experimental subjects. Because this biological agent alters blood rheology and systemic vascular resistance, research models require strict surveillance of hematological parameters. Investigational applications demand careful handling of its complex glycoprotein structure to preserve biological activity in cold-chain environments.

References

1.Jelkmann et al., Frontiers of Hormone Research, 2016 — Review of erythropoiesis regulation, hemoglobin mass, and glycan isoform detection
2.Palmer et al., Annals of Internal Medicine, 2010 — Meta-analysis of erythropoiesis-stimulating agents and vascular event risks at higher hemoglobin targets
3.Ye et al., Renal Failure, 2018 — Meta-analysis examining target hemoglobin concentrations and fistula thrombosis incidence
4.Breenfeldt Andersen et al., Scandinavian Journal of Medicine & Science in Sports, 2022 — Mechanisms of blood manipulation, endurance performance, and biological monitoring
5.Clyne et al., Thrombosis Research, 1995 — Effects of rHuEPO administration on hematocrit escalation and thrombin-antithrombin complex activation
6.Cantelmo et al., European Journal of Sport Science, 2019 — Analysis of genetic manipulation targets involving erythropoietin pathways